• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Sagent Pharmaceuticals, Inc. (SGNT)

    -NasdaqGS
    24.04 1.88(7.25%) Dec 17, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.9
    Mean Recommendation (last week):2.9
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:32.57
    Median Target:32.00
    High Target:38.00
    Low Target:27.00
    No. of Brokers:7

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jul 31, 2014NeedhamDowngradeBuyHold
    Jan 7, 2014RBC Capital MktsInitiated Underperform
    Aug 10, 2012RBC Capital MktsDowngradeOutperformSector Perform
    Jun 7, 2012NeedhamUpgradeHoldBuy
    Apr 17, 2012AurigaInitiated Buy
    Nov 29, 2011Collins StewartInitiated Buy
    May 31, 2011RBC Capital MktsInitiated Outperform
    Aug 10, 2000Chase H&QUpgradeBuyStrong Buy
    Jun 29, 2000Chase H&QUpgradeMarket PerformBuy
    Apr 19, 2000DLJDowngradeBuyMarket Perform

    More Upgrades & Downgrades for SGNT

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy1111
    Hold7777
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.